Cargando…

106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients

Detalles Bibliográficos
Autores principales: Moghadam, Shahrzad, LaGuardia, Jonnby S., Huang, Kelly X., Bedar, Meiwand, Chin, Madeline G., Lee, Justine C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194729/
http://dx.doi.org/10.1097/01.GOX.0000938012.64707.a4
_version_ 1785044075764776960
author Moghadam, Shahrzad
LaGuardia, Jonnby S.
Huang, Kelly X.
Bedar, Meiwand
Chin, Madeline G.
Lee, Justine C.
author_facet Moghadam, Shahrzad
LaGuardia, Jonnby S.
Huang, Kelly X.
Bedar, Meiwand
Chin, Madeline G.
Lee, Justine C.
author_sort Moghadam, Shahrzad
collection PubMed
description
format Online
Article
Text
id pubmed-10194729
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101947292023-05-19 106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients Moghadam, Shahrzad LaGuardia, Jonnby S. Huang, Kelly X. Bedar, Meiwand Chin, Madeline G. Lee, Justine C. Plast Reconstr Surg Glob Open PSRC 2023 Meeting Abstract Supplement Lippincott Williams & Wilkins 2023-05-19 /pmc/articles/PMC10194729/ http://dx.doi.org/10.1097/01.GOX.0000938012.64707.a4 Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle PSRC 2023 Meeting Abstract Supplement
Moghadam, Shahrzad
LaGuardia, Jonnby S.
Huang, Kelly X.
Bedar, Meiwand
Chin, Madeline G.
Lee, Justine C.
106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients
title 106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients
title_full 106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients
title_fullStr 106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients
title_full_unstemmed 106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients
title_short 106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients
title_sort 106. increased length of gender-affirming hormone therapy is associated with greater facial fat pad volume in transfeminine patients
topic PSRC 2023 Meeting Abstract Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194729/
http://dx.doi.org/10.1097/01.GOX.0000938012.64707.a4
work_keys_str_mv AT moghadamshahrzad 106increasedlengthofgenderaffirminghormonetherapyisassociatedwithgreaterfacialfatpadvolumeintransfemininepatients
AT laguardiajonnbys 106increasedlengthofgenderaffirminghormonetherapyisassociatedwithgreaterfacialfatpadvolumeintransfemininepatients
AT huangkellyx 106increasedlengthofgenderaffirminghormonetherapyisassociatedwithgreaterfacialfatpadvolumeintransfemininepatients
AT bedarmeiwand 106increasedlengthofgenderaffirminghormonetherapyisassociatedwithgreaterfacialfatpadvolumeintransfemininepatients
AT chinmadelineg 106increasedlengthofgenderaffirminghormonetherapyisassociatedwithgreaterfacialfatpadvolumeintransfemininepatients
AT leejustinec 106increasedlengthofgenderaffirminghormonetherapyisassociatedwithgreaterfacialfatpadvolumeintransfemininepatients